SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-23-007384
Filing Date
2023-05-04
Accepted
2023-05-04 18:48:34
Documents
1
Period of Report
2023-05-02

Document Format Files

Seq Description Document Type Size
1 form4-05042023_100524.html 4  
1 form4-05042023_100524.xml 4 5682
  Complete submission text file 0001415889-23-007384.txt   7083
Mailing Address 160 BOVET ROAD, SUITE 408 C/O DELPHI VENTURES SAN MATEO CA 94402
Business Address
PAKIANATHAN DEEPIKA (Reporting) CIK: 0001270734 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36033 | Film No.: 23890610

Mailing Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104
Business Address UGLAND HOUSE, SOUTH CHURCH STREET GEORGE TOWN, GRAND CAYMAN E9 KY1-1104 650-808-6000
Theravance Biopharma, Inc. (Issuer) CIK: 0001583107 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations